|
Fusion gene ID: 12069 |
FusionGeneSummary for ESCO1_ABHD3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ESCO1_ABHD3 | Fusion gene ID: 12069 | Hgene | Tgene | Gene symbol | ESCO1 | ABHD3 | Gene ID | 114799 | 171586 |
Gene name | establishment of sister chromatid cohesion N-acetyltransferase 1 | abhydrolase domain containing 3 | |
Synonyms | A930014I12Rik|CTF|ECO1|EFO1|ESO1 | LABH3 | |
Cytomap | 18q11.2 | 18q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | N-acetyltransferase ESCO1CTF7 homolog 1ECO1 homolog 1EFO1pESO1 homolog 1N-acetyltransferase ESCO1 variant 2establishment factor-like protein 1establishment of cohesion 1 homolog 1hEFO1 | phospholipase ABHD3abhydrolase domain-containing protein 3alpha/beta hydrolase domain containing protein 3lung alpha/beta hydrolase 3 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q5FWF5 | Q8WU67 | |
Ensembl transtripts involved in fusion gene | ENST00000269214, ENST00000580101, | ENST00000289119, ENST00000580981, ENST00000578270, ENST00000579875, | |
Fusion gene scores | * DoF score | 10 X 5 X 7=350 | 4 X 5 X 5=100 |
# samples | 13 | 7 | |
** MAII score | log2(13/350*10)=-1.42884329880387 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/100*10)=-0.514573172829758 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ESCO1 [Title/Abstract] AND ABHD3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ESCO1 | GO:0018394 | peptidyl-lysine acetylation | 27112597 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-D8-A27H-01A | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
TCGA | RV | UCEC | TCGA-B5-A1MS-01B | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
TCGA | LD | UCEC | TCGA-AX-A3G1-01A | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000269214 | ENST00000289119 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
5CDS-intron | ENST00000269214 | ENST00000580981 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
5CDS-5UTR | ENST00000269214 | ENST00000578270 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
5CDS-intron | ENST00000269214 | ENST00000579875 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
intron-3CDS | ENST00000580101 | ENST00000289119 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
intron-intron | ENST00000580101 | ENST00000580981 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
intron-5UTR | ENST00000580101 | ENST00000578270 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
intron-intron | ENST00000580101 | ENST00000579875 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19263926 | - |
Frame-shift | ENST00000269214 | ENST00000289119 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
5CDS-intron | ENST00000269214 | ENST00000580981 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
5CDS-5UTR | ENST00000269214 | ENST00000578270 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
5CDS-5UTR | ENST00000269214 | ENST00000579875 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
intron-3CDS | ENST00000580101 | ENST00000289119 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
intron-intron | ENST00000580101 | ENST00000580981 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
intron-5UTR | ENST00000580101 | ENST00000578270 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
intron-5UTR | ENST00000580101 | ENST00000579875 | ESCO1 | chr18 | 19140820 | - | ABHD3 | chr18 | 19244191 | - |
In-frame | ENST00000269214 | ENST00000289119 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
In-frame | ENST00000269214 | ENST00000580981 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
In-frame | ENST00000269214 | ENST00000578270 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
5CDS-intron | ENST00000269214 | ENST00000579875 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
intron-3CDS | ENST00000580101 | ENST00000289119 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
intron-3CDS | ENST00000580101 | ENST00000580981 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
intron-3CDS | ENST00000580101 | ENST00000578270 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
intron-intron | ENST00000580101 | ENST00000579875 | ESCO1 | chr18 | 19153275 | - | ABHD3 | chr18 | 19239304 | - |
Top |
FusionProtFeatures for ESCO1_ABHD3 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ESCO1 | ABHD3 |
Phospholipase that may play a role in phospholipidsremodeling. May selectively cleave myristate (C14)-containingphosphatidylcholines through its predominant phospholipase 1activity, cleaving preferentially acyl groups in sn1 position. Inparallel, may have a minor phospholipase 2 activity acting on acylgroups in position sn2. In addition to (C14)-containingphosphatidylcholines, may also act on other medium-chain-containing and oxidatively truncated phospholipids.{ECO:0000269|PubMed:21926997}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ESCO1 | chr18:19140820 | chr18:19263926 | ENST00000269214 | - | 8 | 12 | 617_641 | 651 | 841 | Zinc finger | CCHH-type |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >ESCO1 | chr18:19140820 | chr18:19263926 | ENST00000269214 | - | 8 | 12 | 772_774 | 651 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19140820 | chr18:19263926 | ENST00000269214 | - | 8 | 12 | 780_785 | 651 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19140820 | chr18:19263926 | ENST00000269214 | - | 8 | 12 | 812_814 | 651 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19153275 | chr18:19239304 | ENST00000269214 | - | 4 | 12 | 772_774 | 510 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19153275 | chr18:19239304 | ENST00000269214 | - | 4 | 12 | 780_785 | 510 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19153275 | chr18:19239304 | ENST00000269214 | - | 4 | 12 | 812_814 | 510 | 841 | Region | Acetyl-CoA binding |
Hgene | >ESCO1 | chr18:19153275 | chr18:19239304 | ENST00000269214 | - | 4 | 12 | 617_641 | 510 | 841 | Zinc finger | CCHH-type |
Tgene | ABHD3 | chr18:19140820 | chr18:19263926 | ENST00000289119 | - | 2 | 9 | 140_233 | 169 | 410 | Domain | AB hydrolase-1 |
Tgene | ABHD3 | chr18:19153275 | chr18:19239304 | ENST00000289119 | - | 4 | 9 | 140_233 | 222 | 410 | Domain | AB hydrolase-1 |
Tgene | ABHD3 | chr18:19140820 | chr18:19263926 | ENST00000289119 | - | 2 | 9 | 26_46 | 169 | 410 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Tgene | ABHD3 | chr18:19153275 | chr18:19239304 | ENST00000289119 | - | 4 | 9 | 26_46 | 222 | 410 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
FusionGeneSequence for ESCO1_ABHD3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_ESCO1_ENST00000269214_chr18_19140820_-_ABHD3_ENST00000289119_chr18_19263926_-_891aa MMSIQEKSKENSSKVTKKSDDKNSETEIQDSQKNLAKKSGPKETIKSQAKSSSESKINQPELETRMSTRSSKAASNDKATKSINKNTVTV RGYSQESTKKKLSQKKLVHENPKANEQLNRRSQRLQQLTEVSRRSLRSREIQGQVQAVKQSLPPTKKEQCSSTQSKSNKTSQKHVKRKVL EVKSDSKEDENLVINEVINSPKGKKRKVEHQTACACSSQCTQGSEKCPQKTTRRDETKPVPVTSEVKRSKMATSVVPKKNEMKKSVHTQV NTNTTLPKSPQPSVPEQSDNELEQAGKSKRGSILQLCEEIAGEIESDNVEVKKESSQMESVKEEKPTEIKLEETSVERQILHQKETNQDV QCNRFFPSRKTKPVKCILNGINSSAKKNSNWTKIKLSKFNSVQHNKLDSQVSPKLGLLRTSFSPPALEMHHPVTQSTFLGTKLHDRNITC QQEKMKEINSEEVKINDITVEINKTTERAPENCHLANEIKPSDPPLDNQMKHSFDSASNKNFSQCLESKLENSPVENVTAASTLLSQAKI DTGENKFPGSAPQQHSILSNQTSKSSDNRETPRNHSLPKCNSHLEITIPKDLKLKEAEKTDEKQLIIDAGQKRFGAVSCNVCGMLYTASN PEDETQHLLFHNQFISAVKYVMCGFXQQRSGGGESLDAKDLLLCXHXRLGDSYSPCTQPVPFCSFPGSRGFNGRNAASKLLGQNWVQNAF DGSCNFFRWLEHLRLLRVIGKTTELATFXLLFDNLPSVFSXXAPTYVCKTSXYGSCHEGXIHQRVXXAIHFSHVWIPNNXXLLYXCQSES |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_ESCO1_ENST00000269214_chr18_19140820_-_ABHD3_ENST00000289119_chr18_19263926_-_2674nt ATGATGTCCATTCAGGAGAAATCAAAAGAGAATTCCTCCAAAGTTACTAAAAAAAGTGACGATAAGAATTCAGAAACAGAAATTCAGGAT TCTCAAAAGAATCTAGCAAAAAAATCAGGTCCAAAGGAGACTATAAAATCACAGGCTAAATCTTCCAGTGAAAGTAAAATAAATCAGCCA GAATTGGAAACACGCATGAGTACAAGGTCATCAAAGGCAGCATCTAATGATAAAGCTACTAAATCCATTAATAAAAATACGGTGACTGTG AGGGGATATTCACAAGAATCTACAAAAAAGAAATTATCTCAGAAAAAATTAGTACATGAAAACCCTAAAGCAAATGAACAGCTTAACCGG AGATCACAAAGGCTACAACAATTAACAGAGGTTTCAAGAAGGTCGTTACGCAGTAGAGAAATTCAGGGTCAAGTTCAAGCAGTTAAACAG AGTTTGCCACCAACTAAAAAAGAGCAGTGTAGCAGTACTCAGAGTAAATCTAATAAAACAAGTCAAAAACATGTGAAGAGAAAAGTACTG GAAGTAAAGTCTGACTCTAAAGAAGATGAAAATCTAGTAATTAATGAAGTAATAAATTCTCCCAAAGGGAAAAAACGCAAGGTAGAACAT CAGACAGCTTGTGCTTGTAGTTCTCAATGCACGCAAGGATCTGAAAAGTGTCCTCAGAAGACTACTAGAAGAGACGAAACGAAACCTGTG CCTGTAACTTCTGAGGTGAAAAGATCAAAAATGGCTACTTCAGTGGTCCCGAAAAAGAATGAGATGAAGAAGTCGGTTCATACACAAGTG AATACTAACACAACACTCCCAAAAAGTCCACAGCCATCAGTGCCTGAACAAAGTGATAATGAGCTGGAGCAAGCAGGAAAGAGCAAACGA GGTAGTATTCTCCAGCTCTGTGAAGAAATTGCTGGTGAAATTGAGTCAGATAATGTAGAGGTAAAAAAGGAATCTTCACAAATGGAAAGT GTAAAGGAAGAAAAGCCCACAGAAATAAAATTGGAAGAGACCAGTGTTGAAAGACAAATACTTCATCAGAAGGAAACAAATCAGGATGTG CAATGTAATCGTTTTTTCCCAAGTAGAAAAACAAAGCCTGTGAAATGTATACTAAATGGAATAAACAGCTCAGCCAAGAAGAACTCCAAC TGGACTAAAATTAAACTCTCAAAATTTAACTCTGTGCAGCACAATAAGTTGGACTCTCAAGTTTCCCCTAAATTAGGCTTATTACGAACC AGTTTTTCACCACCAGCTTTAGAAATGCATCATCCAGTGACTCAAAGTACGTTTTTAGGGACAAAGCTACATGATAGAAATATAACTTGC CAGCAGGAAAAAATGAAAGAAATTAATTCTGAAGAAGTGAAAATTAATGATATTACAGTAGAAATTAATAAAACCACAGAAAGGGCTCCT GAAAATTGTCATTTGGCCAATGAGATAAAACCTTCTGACCCACCATTGGATAATCAGATGAAACATTCTTTTGATTCAGCATCAAATAAG AATTTCAGCCAATGTTTGGAATCCAAGCTAGAAAACAGTCCAGTGGAAAATGTTACTGCTGCTTCGACTCTGCTCAGTCAAGCAAAAATT GATACAGGAGAGAATAAATTTCCAGGTTCAGCTCCCCAACAGCATAGTATTCTCAGTAACCAGACATCTAAAAGCAGTGATAACAGGGAG ACACCACGAAATCATTCTTTGCCTAAGTGTAATTCCCATTTGGAGATAACAATTCCAAAGGACTTGAAACTAAAAGAAGCAGAGAAAACT GATGAAAAACAGTTGATTATAGATGCAGGACAAAAAAGATTTGGAGCAGTTTCTTGTAATGTTTGTGGAATGCTGTATACAGCTTCAAAT CCAGAAGATGAAACACAGCATCTGCTTTTCCACAACCAGTTTATAAGTGCTGTTAAATATGTGATGTGTGGTTTTTAACAACAGAGGAGT GGCGGGGGAGAATCTCTTGACGCCAAGGACTTATTGTTGTGCTAACACTGAAGACTTGGAGACAGTTATTCACCATGTACACAGCCTGTA CCCTTCTGCTCCTTTCCTGGCAGCAGGGGTTTCAATGGGAGGAATGCTGCTTCTAAATTACTTGGGCAAAATTGGGTCCAAAACGCCTTT GATGGCAGCTGCAACTTTTTCCGTTGGTTGGAACACCTTCGCTTGCTCAGAGTCATTGGAAAAACCACTGAACTGGCTACTTTTTAATTA CTATTTGACAACCTGCCTTCAGTCTTCAGTTAATAAGCACCGACATATGTTTGTAAAACAAGTTGATATGGATCATGTCATGAAGGCTAA ATCCATCAGAGAGTTTGATAAGCGATTCACTTCAGTCATGTTTGGATACCAAACAATTGATGATTATTATACTGATGCCAGTCCGAGTCC TAGACTGAAGTCAGTAGGAATTCCAGTATTGTGTCTAAATTCTGTGGATGATGTTTTCTCACCCAGTCATGCTATTCCAATAGAAACTGC TAAGCAAAATCCTAATGTTGCTTTGGTCCTTACTTCTTATGGAGGCCATATTGGTTTTCTGGAGGGAATCTGGCCAAGACAGTCCACTTA |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_ESCO1_ENST00000269214_chr18_19140820_-_ABHD3_ENST00000289119_chr18_19263926_-_4306nt GTTTGCGCCGCGGGGGAGGCGGCGGCCGCAGCAGAAGCAGCTGAGTGTCTCCTGATACCCGGATGTGAGGCGATCCGCTGGCGCTAGTCT GACCCTCCGCCAGGCAAAAGGAAGATTGTCTTTGGCTATAGAGTTTTTTTTTTTAAAGATTACTAAACATACAGGAAGTGATAAGAAGTA TCATTCATCAGAAGCATCATTCATCAATCAACTTGAAGAAAAAGGTGATATATTATTTCTTTAAGGTGCTGTGTGATGTGTTAAGAGCAT ATTAGAAGGAATGGTTTTGTCTAATTTTCTTCATGAGTTATGGTGGCTGAGACATCGAGTCTATATTTTGGGGCAAAAACTAAACGGCAG CACAAAAGGAAATCTATATTAATAGAATATTTTGTTGAACAAAGGAGGTTAGATAAGAACTGCAAACCAACAGACTCAGCAAACAAGGAA AGAAACGTGTTAGCCATAAGACATGTTTCAAGTGAATCGAAGTCCAATAACTGTAGACTTCAGAAGAAAAAAGTTTTCAAAAATTTTATC AAAACAGGTCACTGATAAATAACTCCTCCAGTAATAGAGCTAGGCCTGAAACCAAAATTAATTAAAAAATTAACAAAACAGATTGAACCT GAATTAAATTTCTTTTGATAAAAAAACTTATTAAAAATAATCAAAATTTTCCTCAAATTTTTATTACCTTGTCCAAAGTAAAGCAAGTGT CTTTTAGCATTCATGCCAGCTTTTCTCATGTTCTAGGAATGACAGAAACCTTACTTGAAGCAAACTAGTATTTTTGTTGAAAATGTATAT CAGCATCAGTTAAAGTTGATTTTTCAGACCTGCTCCTCAGTAATAATACTAGCTAGTCAGCATTCACGCCTACCAGGACACAAAAATCCT CTTCAAAACTACTCAGAAAAGAAAGTCATTACTCAGGAATGATGTCCATTCAGGAGAAATCAAAAGAGAATTCCTCCAAAGTTACTAAAA AAAGTGACGATAAGAATTCAGAAACAGAAATTCAGGATTCTCAAAAGAATCTAGCAAAAAAATCAGGTCCAAAGGAGACTATAAAATCAC AGGCTAAATCTTCCAGTGAAAGTAAAATAAATCAGCCAGAATTGGAAACACGCATGAGTACAAGGTCATCAAAGGCAGCATCTAATGATA AAGCTACTAAATCCATTAATAAAAATACGGTGACTGTGAGGGGATATTCACAAGAATCTACAAAAAAGAAATTATCTCAGAAAAAATTAG TACATGAAAACCCTAAAGCAAATGAACAGCTTAACCGGAGATCACAAAGGCTACAACAATTAACAGAGGTTTCAAGAAGGTCGTTACGCA GTAGAGAAATTCAGGGTCAAGTTCAAGCAGTTAAACAGAGTTTGCCACCAACTAAAAAAGAGCAGTGTAGCAGTACTCAGAGTAAATCTA ATAAAACAAGTCAAAAACATGTGAAGAGAAAAGTACTGGAAGTAAAGTCTGACTCTAAAGAAGATGAAAATCTAGTAATTAATGAAGTAA TAAATTCTCCCAAAGGGAAAAAACGCAAGGTAGAACATCAGACAGCTTGTGCTTGTAGTTCTCAATGCACGCAAGGATCTGAAAAGTGTC CTCAGAAGACTACTAGAAGAGACGAAACGAAACCTGTGCCTGTAACTTCTGAGGTGAAAAGATCAAAAATGGCTACTTCAGTGGTCCCGA AAAAGAATGAGATGAAGAAGTCGGTTCATACACAAGTGAATACTAACACAACACTCCCAAAAAGTCCACAGCCATCAGTGCCTGAACAAA GTGATAATGAGCTGGAGCAAGCAGGAAAGAGCAAACGAGGTAGTATTCTCCAGCTCTGTGAAGAAATTGCTGGTGAAATTGAGTCAGATA ATGTAGAGGTAAAAAAGGAATCTTCACAAATGGAAAGTGTAAAGGAAGAAAAGCCCACAGAAATAAAATTGGAAGAGACCAGTGTTGAAA GACAAATACTTCATCAGAAGGAAACAAATCAGGATGTGCAATGTAATCGTTTTTTCCCAAGTAGAAAAACAAAGCCTGTGAAATGTATAC TAAATGGAATAAACAGCTCAGCCAAGAAGAACTCCAACTGGACTAAAATTAAACTCTCAAAATTTAACTCTGTGCAGCACAATAAGTTGG ACTCTCAAGTTTCCCCTAAATTAGGCTTATTACGAACCAGTTTTTCACCACCAGCTTTAGAAATGCATCATCCAGTGACTCAAAGTACGT TTTTAGGGACAAAGCTACATGATAGAAATATAACTTGCCAGCAGGAAAAAATGAAAGAAATTAATTCTGAAGAAGTGAAAATTAATGATA TTACAGTAGAAATTAATAAAACCACAGAAAGGGCTCCTGAAAATTGTCATTTGGCCAATGAGATAAAACCTTCTGACCCACCATTGGATA ATCAGATGAAACATTCTTTTGATTCAGCATCAAATAAGAATTTCAGCCAATGTTTGGAATCCAAGCTAGAAAACAGTCCAGTGGAAAATG TTACTGCTGCTTCGACTCTGCTCAGTCAAGCAAAAATTGATACAGGAGAGAATAAATTTCCAGGTTCAGCTCCCCAACAGCATAGTATTC TCAGTAACCAGACATCTAAAAGCAGTGATAACAGGGAGACACCACGAAATCATTCTTTGCCTAAGTGTAATTCCCATTTGGAGATAACAA TTCCAAAGGACTTGAAACTAAAAGAAGCAGAGAAAACTGATGAAAAACAGTTGATTATAGATGCAGGACAAAAAAGATTTGGAGCAGTTT CTTGTAATGTTTGTGGAATGCTGTATACAGCTTCAAATCCAGAAGATGAAACACAGCATCTGCTTTTCCACAACCAGTTTATAAGTGCTG TTAAATATGTGATGTGTGGTTTTTAACAACAGAGGAGTGGCGGGGGAGAATCTCTTGACGCCAAGGACTTATTGTTGTGCTAACACTGAA GACTTGGAGACAGTTATTCACCATGTACACAGCCTGTACCCTTCTGCTCCTTTCCTGGCAGCAGGGGTTTCAATGGGAGGAATGCTGCTT CTAAATTACTTGGGCAAAATTGGGTCCAAAACGCCTTTGATGGCAGCTGCAACTTTTTCCGTTGGTTGGAACACCTTCGCTTGCTCAGAG TCATTGGAAAAACCACTGAACTGGCTACTTTTTAATTACTATTTGACAACCTGCCTTCAGTCTTCAGTTAATAAGCACCGACATATGTTT GTAAAACAAGTTGATATGGATCATGTCATGAAGGCTAAATCCATCAGAGAGTTTGATAAGCGATTCACTTCAGTCATGTTTGGATACCAA ACAATTGATGATTATTATACTGATGCCAGTCCGAGTCCTAGACTGAAGTCAGTAGGAATTCCAGTATTGTGTCTAAATTCTGTGGATGAT GTTTTCTCACCCAGTCATGCTATTCCAATAGAAACTGCTAAGCAAAATCCTAATGTTGCTTTGGTCCTTACTTCTTATGGAGGCCATATT GGTTTTCTGGAGGGAATCTGGCCAAGACAGTCCACTTACATGGATCGTGTCTTCAAGCAATTTGTGCAAGCCATGGTTGAGCATGGACAT GAACTCTCTTAACATGTAGTTCTTTGGGTGCATTTTGTCTGAACCACAATTGTGAAGGCAGCTCAGCTTAGTGCACAAATTTTAACTGTT GTATATAAAGCAAATAAGCCAGCAGATGGGTGAAGAGGTCCAGAATGATATGCAAAAACTACTTTTTAGAGAAACAAAACAACTTTGTAG CAACAAATTAAATATAGTATTAGATTGTTACTTACGTAGATTTTATTTTTACTATGCCTTACCAAGTACATCCTTAAACAAAGTAGTATG TACATGAAATTGCACTTAACCAAAACTATTGTGTAAAACAAATTTTAATTCCTCAGGGTTTTAATTTAAACTAGTATTTTTTTAGATTAT TTGTTTTAGGTGATTTAATGGTACTTTAATAACTACTAAGAAATATTGGCTATTTCAATGTAAGTTATAAGGTGGTACATTCCTAAGGGT ATTTATAGTTGATGATAACATGAAAACTGAAATAAGATAAAATACAACGTGCTAAATCTTTTATGTATTCTAACTTTAAAAGACAAGTGC AACAAAGTTAGACTGACTTCTATATGTGCTCTTTTACTCTGATAATATTAAATTAGGACTAACTTATGTTTTATAATGATTATAATTTAC |
Top |
FusionGenePPI for ESCO1_ABHD3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ESCO1 | KDM1A, HDAC1, HDAC2, HIST1H3A, EHMT2, SUV39H1, SETDB1, HECW2, CDK1, FGFR1OP, CBX8, SMC6, TRIM25 | ABHD3 | KLK15, ATP1B3, HTR3C, MAS1, HTR3A, IL17RC |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ESCO1_ABHD3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ESCO1_ABHD3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |